Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Regulatory News

Date Source Headline
23rd Jan 2019 10:19 am RNS Investor presentations
22nd Jan 2019 7:00 am RNS Appointment of Chairman
13th Dec 2018 7:00 am RNS US New Drug Application PDUFA date for Feraccru
5th Dec 2018 10:04 am RNS UK launch of Feraccru® by Norgine
3rd Dec 2018 7:00 am RNS New Drug Application for Feraccru®
9th Nov 2018 3:46 pm RNS Holding(s) in Company
8th Nov 2018 6:21 pm RNS Holding(s) in Company
1st Oct 2018 1:54 pm RNS Notification Of Major Holdings
1st Oct 2018 7:00 am RNS Submission of an NDA for Feraccru® with the FDA
24th Sep 2018 1:06 pm RNS Director/PDMR Shareholding
24th Sep 2018 1:02 pm RNS Holding(s) in Company
19th Sep 2018 7:14 am RNS Licence for the commercialisation of Feraccru
19th Sep 2018 7:12 am RNS Interim Results
13th Sep 2018 7:00 am RNS AEGIS-H2H Completion of Recruitment
26th Jul 2018 7:00 am RNS Appointment of Non-Executive Director
23rd Jul 2018 7:00 am RNS Business Update
9th Jul 2018 4:27 pm RNS Holdings in Company
9th Jul 2018 4:26 pm RNS Holdings in Company
28th Jun 2018 11:56 am RNS Result of AGM
28th Jun 2018 7:00 am RNS Data from real-world clinical use of Feraccru
14th Jun 2018 7:00 am RNS Positive top-line results from AEGIS-PAED PK study
5th Jun 2018 7:00 am RNS Directorate Change
5th Jun 2018 7:00 am RNS 2017 Annual Report and 2018 AGM Notice
15th May 2018 6:21 pm RNS Grant of share options
4th May 2018 9:20 am RNS Holding(s) in Company
3rd May 2018 5:26 pm RNS Holding(s) in Company
2nd May 2018 11:00 am RNS Price Monitoring Extension
11th Apr 2018 7:00 am RNS Preliminary Results for the Year Ended 31 Dec 17
6th Apr 2018 7:00 am RNS Appointment of Non-Executive Director
6th Apr 2018 7:00 am RNS Results of Pre-Submission Meeting with FDA
27th Mar 2018 7:00 am RNS Broadening of Feraccru indication
16th Mar 2018 7:00 am RNS Update on the AEGIS-CKD study
23rd Feb 2018 1:56 pm RNS Receives CHMP positive opinion on Feraccru®
22nd Feb 2018 7:00 am RNS Business and Trading Update
5th Feb 2018 7:00 am RNS Top-line results from Feraccru Phase III study
29th Jan 2018 7:00 am RNS Notice of Results
25th Jan 2018 7:00 am RNS Grant of share options
10th Oct 2017 7:00 am RNS Completion of patient enrolment in Phase 3 study
5th Oct 2017 7:00 am RNS PDMR Acquisition of Shares
20th Sep 2017 7:00 am RNS Interim Report
FTSE 100 Latest
Value9,645.62
Change67.05